Jeremy G. Chadwick, Chief Operating Officer at Kymera Therapeutics, Inc. (KYMR), sold 11,916 shares at $87.75 ($1.0M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $1.0M KYMR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.75 | 549 | $48K | 4.7% |
| 2 | $87.75 | 549 | $48K | 4.7% |
| 3 | $88.50 | 383 | $34K | 3.3% |
| 4 | $88.50 | 383 | $34K | 3.3% |
| 5 | $89.66 | 1,107 | $99K | 9.6% |
| 6 | $89.66 | 1,107 |
| $99K |
| 9.6% |
| 7 | $84.00 | 394 | $33K | 3.2% |
| 8 | $84.00 | 394 | $33K | 3.2% |
| 9 | $85.04 | 2,017 | $172K | 16.6% |
| 10 | $85.04 | 2,017 | $172K | 16.6% |
| 11 | $85.78 | 1,150 | $99K | 9.6% |
| 12 | $85.78 | 1,150 | $99K | 9.6% |
| 13 | $86.62 | 358 | $31K | 3.0% |
| 14 | $86.62 | 358 | $31K | 3.0% |
| Total | $86.54 avg | 11,916 | $1.0M | 100% |
| Filing → |
| KYMR | SELL | 2026-04-16 | $590K | — | Filing → |
| KYMR | SELL | 2026-04-01 | $1.9M | — | Filing → |
| KYMR | SELL | 2026-03-25 | $18.0M | — | Filing → |